Drugs / CE/MPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00745108 Comparator | Oct 2001 → Jul 2005 | — | Organon and Co | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CE/MPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00745108 ↗ |
| Route | Oral | “oral, 0.625 mg tablet conjugated equine estrogen and 2.5 mg medroxyprogesterone acetate tablet placed together in a single capsule, once daily, for 2 years” NCT00745108 ↗ |